|28th August 2020||Jeremy M Levin||8,488||Open or private purchase||$5.84||$49,569.92|
|8th October 2019||Jeremy M Levin||60,000||Open or private purchase||$2.50||$150,000.00|
|8th October 2019||Pharmaceutical Co Ltd Takeda||2,000,000||Open or private purchase||$2.50||$5,000,000.00|
|26th February 2019||Karen Bernstein||10,000||Open or private purchase||$2.02||$20,210.00|
|22nd February 2019||Jeremy M Levin||75,000||Open or private purchase||$2.00||$150,000.00|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 9/10.
Ovid Therapeutics, Inc. focuses on developing medicines for patients with rare neurological disorders. The company was founded by Matthew During in April 2014 and is headquartered in New York, NY.